M&A Deal Summary |
|
|---|---|
| Date | 2016-10-12 |
| Target | Precipio Diagnostics |
| Sector | Life Science |
| Buyer(s) | Transgenomic |
| Deal Type | Merger |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1997 |
| Sector | Life Science |
| Employees | 150 |
| Revenue | 27M USD (2014) |
Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in oncology, cardiology, neurology, and inherited diseases through advanced diagnostic technologies, products and services. Transgenomic also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Merger M&A Deals | 1 of 1 |
| State: Connecticut M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2016 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-09-10 |
Concise Separations
San Jose, California, United States Concise Separations is a chemical analysis technique that separates and analyzes different substances according to their affinities for chemically stable, highly reactive, synthetic ion exchangers. |
Sell | - |